Dr. med. Wolf Rösler

Department of Medicine 5 – Haematology and Oncology

Vaccination after Allogenic Stem Cell Transplantation: Diminished Memory B Cell Response and High Number of Spontaneously IgG Secreting Plasmablasts (2018) Tittlbach H, Schneider A, Buchstaller C, Mayr A, Vasova I, Rösler W, Mackensen A, et al. Conference contribution Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report (2018) Sahebi F, Garderet L, Kanate AS, Eikema DJ, Knelange NS, Alvelo OF, Koc Y, et al. Journal article Depletion of donor-specific anti-HLA A2 alloantibodies in a hematopoietic cell transplant recipient using directed mismatched platelet transfusions (2018) Spriewald BM, Bach C, Zingsem J, Strobel J, Winkler J, Mackensen A, Rösler W Journal article MAGIC biomarkers predict long term outcomes for steroid-resistant acute GVHD (2018) Major-Monfried H, Renteria AS, Pawarode A, Reddy P, Ayuk F, Holler E, Efebera YA, et al. Journal article Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Mueller TA, et al. Journal article Lenalidomide, adriamycin, dexamethasone (RAD) for induction followed by stem-cell transplant in newly diagnosed myeloma (2017) Knop S, Langer C, Engelhardt M, Muegge LO, Reichle A, Rösler W, Bassermann F, et al. Journal article Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma (2017) Einsele H, Knop S, Vogel M, Mueller J, Kropff M, Metzner B, Langer C, et al. Journal article Allogeneic Hematopoietic Cell Transplantation in Intermediate Risk Acute Myeloid Leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA Mutations (2017) Heidrich K, Thiede C, Schaefer-Eckart K, Schmitz N, Aulitzky WE, Kraemer A, Rösler W, et al. Journal article Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial (2017) Einsele H, Engelhardt M, Tapprich C, Mueller J, Liebisch P, Langer C, Kropff M, et al. Journal article Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial (2017) Middeke JM, Herbst R, Parmentier S, Bug G, Hänel M, Stuhler G, Schäfer-Eckart K, et al. Journal article